Atlas Trials

A Prospective, Non-interventional Study of the Use of Dolutegravir as Part of Combination Antiretroviral Therapy in Routine Daily Practice in Germany

Clinical trial NCT02076386 · COMPLETED

Trial details

NCT number
NCT02076386
Sponsor
ViiV Healthcare
Status
COMPLETED
Study type
OBSERVATIONAL
Infection, Human Immunodeficiency Virus
Start date
2014-03-04
Primary completion
2017-07-05
Enrollment
411

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.